Response to 'Procalcitonin is a biomarker for disease severity rather than bacterial coinfection in COVID-19' by Heer et al.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Lippincott Williams and Wilkins
2022
|
| Online Access: | View Fulltext in Publisher |